Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioAtla LLC
Description Conditionally active biologic (CAB) targeting cytotoxic T-lymphocyte associated protein 4 (CTLA4; CD152)
Molecular Target Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)
Mechanism of ActionImmune checkpoint inhibitor
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today